Fujifilm Showcases Enhanced Cloud-based Synapse® Enterprise Imaging Portfolio at the 2023 Radiological Society of North America Conference
LEXINGTON, Mass., Nov. 22, 2023 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, will showcase its enhanced Synapse® Enterprise Imaging portfolio in booth #1929 at the upcoming Radiological Society of North America ( RSNA ) conference held November 26 – 30 at McCormick Place in Chicago.
- LEXINGTON, Mass., Nov. 22, 2023 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, will showcase its enhanced Synapse® Enterprise Imaging portfolio in booth #1929 at the upcoming Radiological Society of North America ( RSNA ) conference held November 26 – 30 at McCormick Place in Chicago.
- Fujifilm will showcase the following new specialty-specific features and benefits of Synapse 7x version 7.4 in booth #1929.
- The technology was acquired by Fujifilm in 2023 and is the only FDA-cleared pathology solution for primary diagnosis with multiple scanners.
- In addition to these new features, Fujifilm’s entire Synapse Enterprise Imaging portfolio will be available for demonstration, including:
Synapse Cloud provides a scalable and secure environment to host and manage the Synapse Enterprise Imaging portfolio.